HCA vs UHS

Key Takeaways

• HCA is the larger, more diversified operator, running 190 hospitals and roughly 2,500 ambulatory sites, and trades at a meaningfully higher valuation.
• UHS holds a distinctive position as a major behavioral health provider (338 inpatient behavioral facilities), a segment with different demand dynamics than acute care.
• HCA delivered stronger recent profit momentum, while UHS offers a lower valuation with a forward price-to-earnings multiple well below its peer average.
• Both companies face similar policy headwinds tied to Medicaid supplemental payments and expiring health insurance exchange subsidies.
• Relative performance has favored HCA in recent weeks, but UHS presents a contrasting value-versus-momentum trade-off for investors.

Introduction

HCA Healthcare and Universal Health Services are two of the largest publicly traded hospital and healthcare facility operators in the United States. Although both generate the bulk of their revenue from acute care hospitals, their portfolios, geographic footprints, and growth profiles differ considerably, making this a useful stock comparison for investors weighing scale and momentum against valuation and specialized exposure. This analysis reviews recent market activity, operating results, and sentiment shifts for HCA and UHS, and examines how their relative market positioning has evolved in the current environment.

HCA Overview and Recent Performance

HCA Healthcare is the largest for-profit hospital operator in the United States, operating 190 hospitals and approximately 2,500 ambulatory care sites—including surgery centers, freestanding emergency rooms, and urgent care clinics—across 19 states and the United Kingdom. Its scale and dense regional networks give it significant negotiating power and operational leverage.

Recent market activity has been favorable for HCA. In its most recent quarterly report, the company posted adjusted earnings per share (EPS) that exceeded analyst expectations on the back of steady same-facility admission growth, while full-year revenue rose roughly 7% and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) expanded by double digits. Management also authorized a substantial new share repurchase program and raised its dividend, signaling confidence in cash generation. The stock has traded near multi-year highs in recent weeks, reflecting investor optimism around resilient volumes and disciplined expense management.

UHS Overview and Recent Performance

Universal Health Services operates a more concentrated portfolio centered on two segments: acute care hospitals and behavioral health facilities. The company runs 29 acute care hospitals, 338 inpatient behavioral health facilities, and 61 outpatient facilities across 39 states, Washington D.C., the United Kingdom, and Puerto Rico. Its scale in behavioral health—a specialized, less commoditized area of care—differentiates it from larger acute-care peers.

UHS has posted solid but comparatively mixed recent results. Quarterly revenue grew about 9% year over year, driven by higher net revenue per admission across both segments, while adjusted EPS rose sharply on an annual basis but came in slightly below consensus amid softer-than-expected volumes and elevated operating costs. The company continued its long-running share repurchase program and issued forward guidance implying continued revenue and EBITDA growth. Its shares have appreciated over the past year but at a more measured pace than some large-cap peers, keeping its valuation notably lower.

Trending AI Robots

Tickeron's Trending AI Robots page showcases a curated selection of the platform's best-performing automated trading bots for current market conditions. While Tickeron offers hundreds of AI trading bots that collectively trade thousands of different tickers, only a small subset earns a place in this featured section. These bots vary widely in trading style, strategy, timeframe, historical performance, and the universe of tickers they trade—ranging from short-term momentum strategies to longer-horizon trend-following approaches. Some bots target high-turnover intraday setups, while others focus on sustained directional moves in large-cap names such as HCA and UHS. Investors exploring data-driven approaches can review the Trending AI Robots to identify strategies aligned with their own objectives.

Head-to-Head Comparison

Business model is a key point of contrast. HCA relies on broad geographic diversification and an extensive ambulatory network, whereas UHS derives meaningful exposure from behavioral health, a segment with steadier, less cyclical demand characteristics. Growth drivers also differ: HCA emphasizes network expansion and outpatient investment, while UHS leans on pricing improvements and its specialized behavioral footprint.

On valuation, the gap is pronounced. UHS trades at a forward price-to-earnings multiple near the single digits—well below HCA's mid-teens multiple and below its own historical median. Recent momentum, however, has favored HCA, whose shares have responded to stronger earnings beats and a larger capital-return program. Both face common risk factors, including labor costs and policy exposure to Medicaid supplemental payments and expiring exchange subsidies, but UHS's more concentrated footprint and lower liquidity buffer leave it comparatively more sensitive to reimbursement changes.

Tickeron AI Verdict

Based on observable factors, Tickeron's AI would likely favor HCA for its more consistent trend consistency, stronger recent earnings momentum, and larger scale relative to the same sector headwinds. HCA's steady volume growth, expanding margins, and substantial buyback authorization support a more constructive relative positioning. That said, UHS presents a credible value case given its discounted valuation and differentiated behavioral health exposure, and could become more attractive if sentiment or momentum shifts. Any AI-driven assessment remains probabilistic, reflecting the balance of current catalysts and positioning rather than a definitive forecast.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations